바로가기 메뉴
본문 바로가기
해더 바로가기
페이지 하단 바로가기
셀트리온 제약
ABOUT US
Company
Leadership
History
CI
Compliance
BUSINESS
Overview
Chemical
Biosimilar
CMO
R&D
About R&D
Platform Tech
Open Innovation
PRODUCT
Products
Facilities
IR
Financial
Governance
Performance
PR
Notices
Press Releases
Images
CAREERS
Talents
Recruiting Process
Job Information
Welfare
SUPPORT
Contact Us
Locations
메뉴 닫기
메뉴 보기
ENG
KOR
ENG
Notices
What’s new at Celltrion Pharm
Home
게시물 검색
All
Title
Contents
공지사항 목록
No
Title
Registration date
4
Collecting shareholder’s opinions to examine whether to proceed with the merger with Celltrion
2024.07.31
3
Notice to shareholders regarding: The conclusion of government financial audit and the Securities & Futures Commission’s review
2022.03.11
2
Notice to shareholders
2022.01.17
1
[Message to Investors] Celltrion Group’s Statement on the development of a therapeutic antibody treatment to combat COVID-19
2020.04.13
1